BANK OF MONTREAL /CAN/ - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 138 filers reported holding SCICLONE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$41,000
+5.1%
3,6090.0%0.00%
Q2 2017$39,000
+44.4%
3,609
+28.0%
0.00%
Q1 2017$27,000
+50.0%
2,819
+52.1%
0.00%
Q4 2016$18,000
-28.0%
1,853
-24.8%
0.00%
Q3 2016$25,000
-24.2%
2,463
-2.8%
0.00%
Q2 2016$33,000
+65.0%
2,534
+36.8%
0.00%
Q1 2016$20,000
+185.7%
1,853
+36.2%
0.00%
Q2 2014$7,0001,3600.00%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,663,281$16,300,0009.19%
Nantahala Capital Management 1,891,328$18,535,0002.06%
Nine Chapters Capital Management LLC 40,700$399,0000.54%
MENTA CAPITAL LLC 396,336$3,884,0000.38%
Sapphire Star Partners LP 30,439$298,0000.34%
TFS CAPITAL LLC 95,432$935,0000.30%
Ativo Capital Management LLC 123,428$1,210,0000.30%
GLG Partners LP 363,188$3,559,0000.17%
GSA CAPITAL PARTNERS LLP 240,013$2,352,0000.13%
Bowling Portfolio Management LLC 68,473$671,0000.11%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders